vs

Side-by-side financial comparison of Agilent Technologies (A) and Coterra (CTRA). Click either name above to swap in a different company.

Agilent Technologies is the larger business by last-quarter revenue ($1.8B vs $1.8B, roughly 1.0× Coterra). Coterra runs the higher net margin — 20.6% vs 17.0%, a 3.6% gap on every dollar of revenue. On growth, Coterra posted the faster year-over-year revenue change (23.8% vs 7.0%). Over the past eight quarters, Coterra's revenue compounded faster (11.8% CAGR vs 6.9%).

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...

Coterra Energy Inc. is an American energy company engaged in hydrocarbon exploration based in Houston, Texas. The company has operations in the Permian Basin, Marcellus Shale, and the Anadarko Basin.

A vs CTRA — Head-to-Head

Bigger by revenue
A
A
1.0× larger
A
$1.8B
$1.8B
CTRA
Growing faster (revenue YoY)
CTRA
CTRA
+16.8% gap
CTRA
23.8%
7.0%
A
Higher net margin
CTRA
CTRA
3.6% more per $
CTRA
20.6%
17.0%
A
Faster 2-yr revenue CAGR
CTRA
CTRA
Annualised
CTRA
11.8%
6.9%
A

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
A
A
CTRA
CTRA
Revenue
$1.8B
$1.8B
Net Profit
$305.0M
$368.0M
Gross Margin
52.6%
Operating Margin
19.6%
31.9%
Net Margin
17.0%
20.6%
Revenue YoY
7.0%
23.8%
Net Profit YoY
-4.1%
23.9%
EPS (diluted)
$1.07
$0.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
A
A
CTRA
CTRA
Q1 26
$1.8B
Q4 25
$1.9B
$1.8B
Q3 25
$1.7B
$1.8B
Q2 25
$1.7B
$1.7B
Q1 25
$1.7B
$2.0B
Q4 24
$1.7B
$1.4B
Q3 24
$1.6B
$1.3B
Q2 24
$1.6B
$1.3B
Net Profit
A
A
CTRA
CTRA
Q1 26
$305.0M
Q4 25
$434.0M
$368.0M
Q3 25
$336.0M
$322.0M
Q2 25
$215.0M
$511.0M
Q1 25
$318.0M
$516.0M
Q4 24
$351.0M
$297.0M
Q3 24
$282.0M
$252.0M
Q2 24
$308.0M
$220.0M
Gross Margin
A
A
CTRA
CTRA
Q1 26
52.6%
Q4 25
53.2%
Q3 25
51.1%
Q2 25
51.9%
Q1 25
53.5%
Q4 24
53.9%
Q3 24
54.2%
Q2 24
54.4%
Operating Margin
A
A
CTRA
CTRA
Q1 26
19.6%
Q4 25
23.8%
31.9%
Q3 25
20.7%
26.8%
Q2 25
18.0%
40.9%
Q1 25
22.4%
34.8%
Q4 24
24.0%
22.5%
Q3 24
21.1%
25.3%
Q2 24
23.1%
23.0%
Net Margin
A
A
CTRA
CTRA
Q1 26
17.0%
Q4 25
23.3%
20.6%
Q3 25
19.3%
18.3%
Q2 25
12.9%
29.5%
Q1 25
18.9%
25.6%
Q4 24
20.6%
20.5%
Q3 24
17.9%
19.5%
Q2 24
19.6%
17.1%
EPS (diluted)
A
A
CTRA
CTRA
Q1 26
$1.07
Q4 25
$1.53
$0.47
Q3 25
$1.18
$0.42
Q2 25
$0.75
$0.67
Q1 25
$1.11
$0.68
Q4 24
$1.23
$0.40
Q3 24
$0.97
$0.34
Q2 24
$1.05
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
A
A
CTRA
CTRA
Cash + ST InvestmentsLiquidity on hand
$1.8B
$114.0M
Total DebtLower is stronger
$3.0B
$3.8B
Stockholders' EquityBook value
$6.9B
$14.8B
Total Assets
$12.8B
$24.2B
Debt / EquityLower = less leverage
0.44×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
A
A
CTRA
CTRA
Q1 26
$1.8B
Q4 25
$1.8B
$114.0M
Q3 25
$1.5B
$98.0M
Q2 25
$1.5B
$192.0M
Q1 25
$1.5B
$186.0M
Q4 24
$1.3B
$2.0B
Q3 24
$1.8B
$843.0M
Q2 24
$1.7B
$1.3B
Total Debt
A
A
CTRA
CTRA
Q1 26
$3.0B
Q4 25
$3.0B
$3.8B
Q3 25
$3.4B
$3.9B
Q2 25
$3.3B
$4.2B
Q1 25
$3.3B
$4.3B
Q4 24
$3.3B
$3.5B
Q3 24
$2.1B
$2.1B
Q2 24
$2.1B
$2.6B
Stockholders' Equity
A
A
CTRA
CTRA
Q1 26
$6.9B
Q4 25
$6.7B
$14.8B
Q3 25
$6.4B
$14.7B
Q2 25
$6.1B
$14.6B
Q1 25
$6.0B
$14.2B
Q4 24
$5.9B
$13.1B
Q3 24
$5.9B
$13.0B
Q2 24
$6.2B
$13.0B
Total Assets
A
A
CTRA
CTRA
Q1 26
$12.8B
Q4 25
$12.7B
$24.2B
Q3 25
$12.2B
$24.0B
Q2 25
$12.2B
$24.0B
Q1 25
$11.9B
$24.0B
Q4 24
$11.8B
$21.6B
Q3 24
$11.0B
$20.1B
Q2 24
$10.9B
$20.8B
Debt / Equity
A
A
CTRA
CTRA
Q1 26
0.44×
Q4 25
0.45×
0.26×
Q3 25
0.53×
0.27×
Q2 25
0.55×
0.29×
Q1 25
0.56×
0.30×
Q4 24
0.57×
0.27×
Q3 24
0.36×
0.16×
Q2 24
0.34×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
A
A
CTRA
CTRA
Operating Cash FlowLast quarter
$268.0M
$970.0M
Free Cash FlowOCF − Capex
$175.0M
FCF MarginFCF / Revenue
9.7%
Capex IntensityCapex / Revenue
5.2%
Cash ConversionOCF / Net Profit
0.88×
2.64×
TTM Free Cash FlowTrailing 4 quarters
$993.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
A
A
CTRA
CTRA
Q1 26
$268.0M
Q4 25
$545.0M
$970.0M
Q3 25
$362.0M
$971.0M
Q2 25
$221.0M
$936.0M
Q1 25
$431.0M
$1.1B
Q4 24
$481.0M
$626.0M
Q3 24
$452.0M
$755.0M
Q2 24
$333.0M
$558.0M
Free Cash Flow
A
A
CTRA
CTRA
Q1 26
$175.0M
Q4 25
$452.0M
Q3 25
$259.0M
Q2 25
$107.0M
Q1 25
$334.0M
Q4 24
$388.0M
Q3 24
$360.0M
Q2 24
$230.0M
FCF Margin
A
A
CTRA
CTRA
Q1 26
9.7%
Q4 25
24.3%
Q3 25
14.9%
Q2 25
6.4%
Q1 25
19.9%
Q4 24
22.8%
Q3 24
22.8%
Q2 24
14.6%
Capex Intensity
A
A
CTRA
CTRA
Q1 26
5.2%
Q4 25
5.0%
Q3 25
5.9%
Q2 25
6.8%
Q1 25
5.8%
Q4 24
5.5%
Q3 24
5.8%
Q2 24
6.5%
Cash Conversion
A
A
CTRA
CTRA
Q1 26
0.88×
Q4 25
1.26×
2.64×
Q3 25
1.08×
3.02×
Q2 25
1.03×
1.83×
Q1 25
1.36×
2.22×
Q4 24
1.37×
2.11×
Q3 24
1.60×
3.00×
Q2 24
1.08×
2.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

A
A

Service Other$525.0M29%
Chemicaland Energy Market$422.0M23%
Agilent Cross Lab$273.0M15%
Environmentaland Forensics Market$177.0M10%
Food Market$166.0M9%
Academiaand Government Market$130.0M7%
Applied Markets$98.0M5%

CTRA
CTRA

Oil And Condensate$941.0M53%
Natural Gas Production$615.0M34%
Natural Gas Liquids Reserves$206.0M12%
Other Revenues$28.0M2%

Related Comparisons